McCormick & Company vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Hunt Valley MD global flavor leader (NYSE: MKC) at $6.72B FY2024 sales (+1%); McCormick/Old Bay/Frank's RedHot/French's brands, B2B Flavor Solutions for McDonald's and KFC, 2025 guidance 0-2% growth vs. Kraft Heinz.
About
McCormick & Company, Incorporated is a Hunt Valley, Maryland-based global leader in flavor — publicly traded on the New York Stock Exchange (NYSE: MKC for voting shares, MKC.V for non-voting shares) as an S&P 500 Consumer Staples component — manufacturing, marketing, and distributing spices, seasoning mixes, condiments, hot sauces, and flavor solutions under the McCormick, Lawry's, Old Bay, French's, Frank's RedHot, Stubb's, Club House, Kamis, and dozens of other branded and private label names through approximately 12,000 employees in 160 countries. In fiscal year 2024 (ending November 2024), McCormick reported net sales of $6.72 billion (+1%), adjusted EPS of $2.95, and a return to volume-led growth after two years of volume softness as consumers adjusted to post-pandemic spice price increases. For fiscal year 2025, McCormick guided 0-2% net sales growth and adjusted EPS of $3.03-$3.08, reflecting a cautious but positive outlook as consumer spending on branded flavor products stabilizes. CEO Brendan Foley, who assumed the role in 2023 (with founder-family member Lawrence Kurzius transitioning to Executive Chairman), focuses McCormick's strategy on global flavor leadership across two segments: Consumer (branded retail spices, seasonings, condiments — approximately 58% of revenue) and Flavor Solutions (B2B flavoring for foodservice chains and food manufacturing — approximately 42% of revenue). McCormick's B2B Flavor Solutions segment supplies the proprietary flavor packets and seasoning mixes used in fast food chains (McDonald's dipping sauces, KFC's Original Recipe flavor system) under undisclosed relationships that are embedded in customers' core product recipes.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.